Contact this trialFirst, we need to learn more about you.
Protein Kinase Inhibitor
Multiple Targeted Therapies for Meningioma
Recruiting1 awardPhase 2
Ypsilanti, Michigan
This trial is studying how well vismodegib, FAK inhibitor GSK2256098, and capivasertib work in treating patients with progressive meningioma.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.